- Home
- SXTP vs IPST Comparison
SXTP vs IPST Comparison
Compare SXTP & IPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | IPST |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.0M |
| IPO Year | 2023 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SXTP | IPST |
|---|---|---|
| Price | $0.86 | $2.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $14.10 | ★ $164.00 |
| AVG Volume (30 Days) | 41.9K | ★ 2.1M |
| Earning Date | 05-15-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.77 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,005,471.00 | ★ $8,402,488.00 |
| Revenue This Year | $33.92 | $70.16 |
| Revenue Next Year | $51.35 | $60.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.49 | 5.41 |
| 52 Week Low | $0.34 | $0.24 |
| 52 Week High | $8.62 | $25.34 |
Technical Indicators
Market Signals| Indicator | SXTP | IPST |
|---|---|---|
| Relative Strength Index (RSI) | 28.41 | 42.61 |
| Support Level | $0.45 | $2.19 |
| Resistance Level | $1.62 | $3.95 |
| Average True Range (ATR) | 0.09 | 0.55 |
| MACD | -0.00 | -0.35 |
| Stochastic Oscillator | 2.03 | 0.00 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
About IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.